Explore evidence

27 %The overall good knowledge of respondents in the test group improved from 27% to 81% after the intervention.

NigeriaVIH/sidapublished 2024BMC public healthPubMeddocument of 5 observations

60 %60% of HIV-infected subjects were receiving ART.

NigeriaVIH/sidapublished 2021Tropical medicine & international health : TM & IHPubMeddocument of 15 observations

2 per_5Globally, two out of five children living with HIV are unaware of their HIV status.

NigeriaVIH/sidapublished 2023BMC pediatricsPubMeddocument of 10 observations

59 %59% of the ART clients investigated received care at secondary level facilities, and 37% of those receiving care at secondary level facilities had interrupted treatment.

NigeriaVIH/sidaobserved 2000-2020published 2021BMC public healthPubMeddocument of 12 observations

90 %Over 90% of the 2.84 million children under 19 years of age living with HIV globally in 2019 resided in sub-Saharan Africa.

NigeriaVIH/sidaobserved 2019published 2024MedicinePubMeddocument of 6 observations

0 casesAmong 1504 enrolled HIV-positive adults in Nigeria, none reported hypersensitivity reaction to abacavir.

NigeriaVIH/sidaobserved April 2016 to April 2017published 2019The Nigerian postgraduate medical journalPubMeddocument of 6 observations

20.5 %Three months after the intervention, the proportion of respondents with normal serum zinc levels improved significantly from 20.5% to 51.9% in the intervention group.

NigeriaVIH/sidapublished 2022African journal of AIDS research : AJARPubMeddocument of 7 observations

4,150 patientsIn the pre-MMD6 group, 4,150 patients were included.

NigeriaVIH/sidapublished 2023African journal of AIDS research : AJARPubMeddocument of 5 observations

1,000 HIV_RNA_copies_per_mLVL non-suppression was defined as having a VL of at least 1000 HIV RNA copies per mL of plasma.

NigeriaVIH/sidapublished 2023BMJ openPubMeddocument of 10 observations

59 %59% of enrolled MSM in Abuja, Nigeria, were HIV infected, with a 95% confidence interval of 54.2% to 63.6%, from August 2016 to August 2017.

NigeriaVIH/sidaobserved August 2016 to August 2017published 2019Journal of global oncologyPubMeddocument of 5 observations

51.9 %Over half (51.9%) of out-of-school youths and about 12% of in-school youths were engaged in at least one HIV/AIDS risk behaviour.

NigeriaVIH/sidapublished 2025BMC public healthPubMeddocument of 3 observations

7.1 yearsPhenoAge acceleration (PhenoAA) was 7.1 years higher in tumor tissues compared to surrounding normal tissues among HIV-negative women.

NigeriaVIH/sidapublished 2022Frontiers in public healthPubMeddocument of 4 observations

4 casesFour cases of HIV-infected infants were reported, said to have been delivered by HIV-negative mothers.

NigeriaVIH/sidapublished 2023Journal of public health (Oxford, England)PubMeddocument of 3 observations

10.5 %From 2013 to 2021, the prevalence of CD4 count of <200 cells per cubic millimeter decreased from 10.5% to 3.1%.

NigeriaVIH/sidaobserved 2013 to 2021published 2024Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 6 observations

50 %Fifty percent of enrolled youth with HIV in Nigeria were male in a single-arm trial.

NigeriaVIH/sidapublished 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 12 observations

26 %Among 224 HIV-1 infected samples from 6 Nigerian cities, the subtype distribution was 26% G/CRF02_AG recombinants.

NigeriaVIH/sidapublished 2016MedicinePubMeddocument of 7 observations

33.6 %Among 1,598 people living with HIV (PLHIV) on antiretroviral therapy (ART) in three states in southern Nigeria surveyed between July and August 2019, 33.6% were willing to pay for premium ART services.

NigeriaVIH/sidaobserved July and August 2019published 2023PloS onePubMeddocument of 9 observations

23 %The proportion of children and adolescents living with HIV aged 2–18 receiving multimonth dispensing increased from 23% (620/2,647) at baseline to 88% (3,992/4,541) at endline (January-March 2021).

NigeriaVIH/sidaobserved January-March 2021published 2023PloS onePubMeddocument of 8 observations

3.1 %HIV prevalence was 3.1%–9.1% at market sites in Nigeria.

NigeriaVIH/sidaobserved 2009-12published 2016PloS onePubMeddocument of 14 observations

90 %9 of 10 (90.0%) HIV-infected subjects died.

Nigeriacarcinome hépatocellulaire · VIH/sidapublished 2021Tropical medicine & international health : TM & IHPubMeddocument of 15 observations

1.1 %The prevalence of HIV-hepatitis B-hepatitis C triple infection among people living with HIV/AIDS in a rural Northern Nigerian community was 1.1%.

Nigeriahépatite B · hépatite C · VIH/sidapublished 2020The Pan African medical journalPubMeddocument of 4 observations

32.2 %Among long-distance truck drivers in Ekiti State, Nigeria, 32.2% knew their HIV status.

NigeriaVIH/sidaobserved 2019published 2021The Nigerian postgraduate medical journalPubMeddocument of 7 observations

64 %Viral load suppression among children and adolescents living with HIV increased from 64% to 92% between baseline (October-December 2019) and endline (January-March 2021).

NigeriaVIH/sidaobserved January-March 2021published 2023PloS onePubMeddocument of 8 observations

10.6 %Thirty-six participants (10.6%) were confirmed as HIV seropositive.

NigeriaVIH/sidapublished 2022JAMA network openPubMeddocument of 7 observations

11.5 %Seventy-eight (11.5%) of 676 tuberculosis patients at the TB DOTS clinic of Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, from January 2017 to December 2021 were HIV positive.

NigeriaVIH/sidaobserved 2017 to 2021published 2024West African journal of medicinePubMeddocument of 14 observations